About Aminex Therapeutics
Aminex Therapeutics is a private company based in Kenmore, Washington. It has reported $34,504,113 raised in six offerings on Form D since July 2014.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 25, 2022 | Dec 5, 2025 | $15,084,670of $30.0M target | 162 | $93,115 | EquityRule 506(b) | Form D ↗ |
| Aug 4, 2021 | Aug 19, 2021 | $6,298,504of $9.1M target | 97 | $64,933 | EquityRule 506(b) | Form D ↗ |
| Jul 31, 2020 | Aug 14, 2020 | $2,865,125of $3.0M target | 96 | $29,845 | DebtRule 506(b) | Form D ↗ |
| May 17, 2018 | Jun 1, 2018 | $8,253,117of $14.1M target | 96 | $85,970 | EquityRule 506(b) | Form D ↗ |
| Oct 29, 2014 | Nov 12, 2014 | $410,000of $2.4M target | 3 | $136K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 26, 2014 | Jul 11, 2014 | $1,592,697of $1.7M target | 22 | $72,395 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, six offerings | $34,504,113 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Aminex Therapeutics's Form D filed Dec 5, 2025.
Earlier filings also listed Stacy Hock (director, last listed Aug 2021), Roger Ulrich (director, last listed Aug 2021), Rhonda Rhyne (director, last listed Aug 2021), Larry Richards (executive officer, last listed Aug 2021), Thomas Graham (chief operating officer and director, last listed Jun 2018), John Rosling (director, last listed Nov 2014) and Donald Mowat (director, last listed Jul 2014).